Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial.

Wang, Xin Shelley; Shi, Qiuling; Mendoza, Tito R; Garcia-Gonzalez, Araceli; Chen, Ting-Yu; Kamal, Mona; Chen, Tsun Hsuan; Heijnen, Cobi; Orlowski, Robert Z; Cleeland, Charles S

Wang, Xin Shelley; Shi, Qiuling; Mendoza, Tito R; Garcia-Gonzalez, Araceli; Chen, Ting-Yu; Kamal, Mona; Chen, Tsun Hsuan; Heijnen, Cobi; Orlowski, Robert Z; Cleeland, Charles S.

Afiliação

Wang XS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1445, Houston, TX, 77030, USA. xswang@mdanderson.org.
Shi Q; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1445, Houston, TX, 77030, USA.
Mendoza TR; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1445, Houston, TX, 77030, USA.
Garcia-Gonzalez A; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1445, Houston, TX, 77030, USA.
Chen TY; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1445, Houston, TX, 77030, USA.
Kamal M; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1445, Houston, TX, 77030, USA.
Chen TH; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1445, Houston, TX, 77030, USA.
Heijnen C; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1445, Houston, TX, 77030, USA.
Orlowski RZ; Department of Lymphoma/Myeloma and Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cleeland CS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1445, Houston, TX, 77030, USA.

Support Care Cancer ; 29(10): 6099-6107, 2021 Oct.

Article em En | MEDLINE | ID: mdl-33792800

Assuntos

Minociclina; Mieloma Múltiplo; Biomarcadores; Método Duplo-Cego; Fadiga; Humanos; Minociclina/efeitos adversos; Mieloma Múltiplo/tratamento farmacológico; Dor

Palavras-chave

Maintenance therapy; Minocycline; Multiple myeloma; Patient-reported outcomes (PROs); Phase II; pain

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Minociclina / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google